PATENT CLAIM ANALYSIS

Application Number: 15966917
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["424", "093210"]

Abstract:
It is intended to provide MSCs for transplantation that have an improved post-transplantation cell survival rate and engraftment rate and are highly safe with fewer adverse reactions, and a method for conveniently producing MSCs for transplantation having a high cell survival rate and engraftment rate. As means therefor, the present invention provides a stem cell for transplantation comprising an MSC capable of overexpressing IL-10.

Claim (Index 16):
The method of  claim 12 , wherein the target tissue is mesenchymal connective tissue, the central nervous system, or the liver.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 91.0
- Lexical Diversity: 1.44681
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13097046', '14652324', '13668120', '11157603', '12149646']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7597063227660116
- 35 USC 102 Novelty (BERT): 0.503748629656798
- Combined Prediction Score: 0.7341105534550902
- Mean Citation Score: 248.66520800000004
- Max Citation Score: 253.31001
- Similarity Product: 178.69105380896153

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test